RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/38070624http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/38070624http://www.w3.org/2000/01/rdf-schema#comment"Acute cerebral ischemia triggers a profound inflammatory response. While macrophages polarized to an M2-like phenotype clear debris and facilitate tissue repair, aberrant or prolonged macrophage activation is counterproductive to recovery. The inhibitory immune checkpoint Programmed Cell Death Protein 1 (PD-1) is upregulated on macrophage precursors (monocytes) in the blood after acute cerebrovascular injury. To investigate the therapeutic potential of PD-1 activation, we immunophenotyped circulating monocytes from patients and found that PD-1 expression was upregulated in the acute period after stroke. Murine studies using a temporary middle cerebral artery (MCA) occlusion (MCAO) model showed that intraperitoneal administration of soluble Programmed Death Ligand-1 (sPD-L1) significantly decreased brain edema and improved overall survival. Mice receiving sPD-L1 also had higher performance scores short-term, and more closely resembled sham animals on assessments of long-term functional recovery. These clinical and radiographic benefits were abrogated in global and myeloid-specific PD-1 knockout animals, confirming PD-1+ monocytes as the therapeutic target of sPD-L1. Single-cell RNA sequencing revealed that treatment skewed monocyte maturation to a non-classical Ly6Clo, CD43hi, PD-L1+ phenotype. These data support peripheral activation of PD-1 on inflammatory monocytes as a therapeutic strategy to treat neuroinflammation after acute ischemic stroke."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.org/dc/terms/identifier"doi:10.1016/j.bbi.2023.12.007"xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Kim E."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Fan J."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Huang J."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Jain A."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Patel K."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Xu R."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Hou Z."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Kim J.E."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Tyler B."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Boussiotis V.A."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Shah P."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Robinson S."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Lim M."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Jackson C.M."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Levitan I."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Koehler R.C."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Lee R.P."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Pant A."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Gonzalez L.F."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Tamargo R.J."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Brem H."xsd:string
http://purl.uniprot.org/citations/38070624http://purl.uniprot.org/core/author"Bibic A."xsd:string